Oncology Institute, Inc. (TOI) Change in Cash (2020 - 2026)

Oncology Institute (TOI) has 7 years of Change in Cash data on file, last reported at -$3.3 million in Q1 2026.

• Quarterly Change in Cash rose 66.92% year-over-year to -$3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.5 million (down 356.76% YoY) and the FY2025 annual result came in at -$16.1 million, down 199.52% from the prior year.
• Change in Cash fell to -$3.3 million in Q1 2026, from $5.9 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $13.6 million in Q2 2023 to a low of -$47.4 million in Q4 2022.
• A 5-year average of -$5.0 million and a median of -$1.4 million in 2023 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2024 — Change in Cash jumped 908.99% — and 2025, when it slumped 2660.16%.
• Tracing TOI's Change in Cash over 5 years: stood at -$47.4 million in 2022, then soared by 112.56% to $6.0 million in 2023, then sank by 61.92% to $2.3 million in 2024, then soared by 160.56% to $5.9 million in 2025, then sank by 155.61% to -$3.3 million in 2026.
• The last three Change in Cash figures came in at -$3.3 million (Q1 2026), $5.9 million (Q4 2025), and -$2.6 million (Q3 2025), per Business Quant data.